List of Peptide Therapies Companies in Georgia - 2

Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company’s lead product candidate is AL001 for the treatment of Alzheimer’s and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient’s immunological system to Alzheimer’s. The company was incorporated in 2016 and is headquartered in Tampa, Florida.

Cambium Oncology is a team of scientists, drug development experts, cancer physicians, and business leaders united in a shared vision of treating cancer with a novel immunotherapeutic that targets the VIP signaling pathway. Emory investigators discovered that small molecule antagonists to the VIP receptor on T cells could augment T cell-mediated immune responses to cancer, viral infections, and vaccines. Cambium scientists developed and patented more potent molecules with longer half-lives that induce potent anti-cancer immune responses to leukemia and pancreatic cancer. Cambium Oncology is poised to transform the immuno-oncology field, with a first-in-class therapeutic against a novel immune checkpoint pathway.